Zai Lab

Zai Lab is a patient-focused, innovative, commercial-stage global biopharmaceutical company based in China and the United States. Founded in 2014, the company is dedicated to discovering, developing, and commercializing transformative therapies that address significant unmet medical needs in oncology, immunology, neuroscience, and infectious diseases. With headquarters in Shanghai and operations spanning the San Francisco Bay area and Cambridge, Massachusetts, Zai Lab has established itself as a pioneer in bringing innovative medicines to patients in Greater China and worldwide.

The company operates across the full pharmaceutical value chain, from discovery and development to manufacturing and commercialization. Zai Lab has built two state-of-the-art manufacturing facilities in Suzhou - one for small molecules and another for biologics - both designed to meet global cGMP standards. The organization has cultivated strategic partnerships with leading global biotech and pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, GSK, Regeneron, argenx, and Vertex, among others. With a team of experienced professionals and a robust pipeline of investigational medicines, Zai Lab continues its mission to positively impact human health by delivering innovative therapies to patients who need them most.